These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 10087941)
1. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Güran S; Pak I Cancer Genet Cytogenet; 1999 Mar; 109(2):108-13. PubMed ID: 10087941 [TBL] [Abstract][Full Text] [Related]
2. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444 [TBL] [Abstract][Full Text] [Related]
3. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. Güran S; Tunca Y; Imirzalioğlu N Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Xing EP; Nie Y; Wang LD; Yang GY; Yang CS Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853 [TBL] [Abstract][Full Text] [Related]
5. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478 [TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related]
9. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766 [TBL] [Abstract][Full Text] [Related]
10. p16INK4A and p15INK4B gene deletions in primary leukemias. Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238 [TBL] [Abstract][Full Text] [Related]
11. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia. Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092 [TBL] [Abstract][Full Text] [Related]
13. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
14. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759 [TBL] [Abstract][Full Text] [Related]
15. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567 [TBL] [Abstract][Full Text] [Related]
16. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Maloney KW; McGavran L; Odom LF; Hunger SP Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes. Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110 [TBL] [Abstract][Full Text] [Related]
18. p53 and p16INK4A mutations during the progression of glomus tumor. Güran S; Tali ET Pathol Oncol Res; 1999; 5(1):41-5. PubMed ID: 10079377 [TBL] [Abstract][Full Text] [Related]
19. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas. Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]